Get started
Author

Nataliya Volodko

Observed names: N Volod'ko, N Volodko, N. A. Volodko, N. Volodko, Nataliya Volod'ko, Н. А. Володько
ORCID: 0000-0001-5603-9658
Observed ORCID: 0000-0001-5603-9658
OpenAlex ID: A5057612842
European consensus statement on expert colposcopy
2023 · A.E. McGee, T. Alibegashvili, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 60
PDF
Tumour-associated macrophages in breast cancer and their prognostic correlations
1998 · N Volodko, A Reiner, et al. · The Breast · 53
Increased levels of the HER1 adaptor protein Ruk l /CIN85 contribute to breast cancer malignancy
2012 · Anatoliy Samoylenko, Bozhena Vynnytska-Myronovska, et al. · Carcinogenesis · 39
Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding
2017 · L Knopfová, E Biglieri, et al. · Oncogene · 26
PDF
Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma.
2006 · O Mayevska, H Shuvayeva, et al. · PubMed · 21
Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 cases
2024 · Pavel Dundr, Jiří Dvořák, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 20
PDF
The Rare Gynecologic Sarcoma Study: Molecular and Clinicopathologic Results of A Project on 379 Uterine Sarcomas
2025 · Pavel Dundr, Jan Hojný, et al. · Laboratory Investigation · 18
FIRST/ENGOT-OV44: A phase 3 clinical trial of dostarlimab (dost) and niraparib (nira) in first-line (1L) advanced ovarian cancer (aOC).
2025 · Anne-Claire Hardy-Bessard, Eric Pujade-Lauraine, et al. · Journal of Clinical Oncology · 13
Low infiltration of tumor-associated macrophages in high c-Myb-expressing breast tumors
2019 · Nataliya Volodko, Taras Gutor, et al. · Scientific Reports · 11
PDF
Decoding the Molecular Landscape of 262 Uterine Sarcomas: RNA-Seq Clustering of Endometrial Stromal Sarcomas, Uterine Tumors Resembling Ovarian Sex Cord Tumors, and Undifferentiated Uterine Sarcomas With Prognostic Insights
2025 · Jan Hojný, Jiří Dvořák, et al. · Laboratory Investigation · 9
Immunohistochemical analysis of 147 cases of low-grade endometrial stromal sarcoma: refining the immunohistochemical profile of LG-ESS on a large, molecularly confirmed series
2025 · Miroslava Flídrová, Pavel Dundr, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 6
PDF
The Role of HE4 in the Follow-Up of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer—CEEGOG OX-01 Study
2024 · Jiri Presl, Pavel Havelka, et al. · Cancers · 3
PDF
New Conceptual Ideas in the Proceedings of the Shevchenko Scientific Society. Medical Sciences (dedicated to the 125th Anniversary Since Its Foundation)
2023 · Oksana Zayachkivska, Vassyl Lonchyna, et al. · Proceedings of the Shevchenko Scientific Society Medical Sciences · 3
PDF
Ukrainian national consensus on the examination and treatment of women after primary cervical screening
2018 · Н. А. Володько, А. Б. Вінницька, et al. · Reproductive Endocrinology · 3
PDF
Cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy) in combined treatment of ovarian cancer: time for the beginning of personalized therapy?
2019 · Roman Yarema, Nataliya Volodko, et al. · Current Issues in Pharmacy and Medical Sciences · 2
PDF
Cancer and Covid-19. a Combat Strategy
2021 · Nazar Lukavetskyy, Nataliya Volod'ko · Proceedings of the Shevchenko Scientific Society Medical Sciences · 1
PDF
Cervical pathology: scope of gynecologist competence
2013 · В. М. Запорожан, Т. Ф. Татарчук, et al. · Reproductive Endocrinology · 1
PDF
1072P Patient-reported outcomes (PROs) with 1L pembrolizumab (pembro) + chemotherapy (chemo) then maintenance pembro + olaparib (ola) in advanced BRCA1/2-nonmutated epithelial ovarian cancer (EOC): Phase III ENGOT-ov43/GOG-3036/KEYLYNK-001 study
2025 · S. Topuz, S. Sharma, et al. · Annals of Oncology
1298 Evaluation of the peritoneal surface disease severity score (PSDSS) in ovarian cancer patients undergoing cytoreductive surgery and HIPEC: two pathogenetic types based study
2024 · Roman Yarema, Nataliya Volodko, et al. · International Journal of Gynecological Cancer
991 Fertility sparing surgery in cervical cancer patients outside controlled trials – a multicenter retrospective cohort trial (CEEGOG Cx-03; ENGOT-CX14)
2021 · J. Sláma, S. Kommoss, et al. · International Journal of Gynecological Cancer
PDF
Cytoreductive surgery and HIPEC in combined treatment of ovarian cancer
2019 · M. Fetsych, R. Yarema, et al. · European Journal of Surgical Oncology
1058 POSTER Adaptor Protein Ruk/CIN85 Expression in Human Tumours
2011 · O. Basaraba, Y.A. Bobak, et al. · European Journal of Cancer
Comparative study of expression of adaptor proteins Ruk/CIN85 and CD2AP/CMS in normal andtumor human uterus tissues
2009 · O. I. Basaraba, Ya. P. Bobak, et al. · Studia Biologica
PDF
Influence of IFN-alpha2b, TGF-beta1 and some chemotherapeutic agents on the proliferation of endothelial cells
2003 · Marta Lomnytska, N. Volodko, et al. · Experimental Oncology
In vitro HUVECs proliferation activity after the influence of the recombinant TNF-α and the supernatants of the primary culture of the tumors and serum of gastric cancer patients
2001 · I. Hipp, N. Volodko, et al. · European Journal of Cancer
Works count: 28
Citation count: 289
H-index: 9
I10-index: 9
Year
Topic
Type